Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Arcutis Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 141
- +2 vs. Q3 2022
- Shares held
- 66.1M
- +6.73M (+11.3%) vs. Q3 2022
- Total value
- $979.6M
- −$154.6M (−13.6%) vs. Q3 2022
- New holders
- 21
- 70 more added
- Sold out
- 19
- 27 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 193,311 | $2.86M | 0.00% | +169,739+720.1% | Added |
| Morgan Stanley | 198,064 | $2.93M | 0.00% | +73,138+58.5% | Added |
| Sectoral Asset Management Inc | 203,852 | $3.02M | 0.58% | −17,133−7.8% | Reduced |
| Bank of America Corp | 239,038 | $3.54M | 0.00% | +87,781+58.0% | Added |
| MPM Oncology Impact Management LP | 262,069 | $3.88M | 1.01% | +4,884+1.9% | Added |
| Goldman Sachs Group Inc | 279,665 | $4.14M | 0.00% | +96,368+52.6% | Added |
| Charles Schwab Investment Management Inc | 301,728 | $4.47M | 0.00% | +10,635+3.7% | Added |
| Rafferty Asset Management, LLC | 303,129 | $4.49M | 0.04% | +129,146+74.2% | Added |
| AXA S.A. | 335,786 | $4.97M | 0.02% | −1,809−0.5% | Reduced |
| Dimensional Fund Advisors LP | 370,490 | $5.48M | 0.00% | +56,547+18.0% | Added |
| Northern Trust Corp | 384,852 | $5.70M | 0.00% | +11,151+3.0% | Added |
| EcoR1 Capital, LLC | 415,322 | $6.15M | 0.19% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 484,552 | $7.17M | 0.02% | −4,793−1.0% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $8.42M | 3.66% | 00.0% | Unchanged |
| American Century Companies Inc | 580,889 | $8.60M | 0.01% | −2,047−0.4% | Reduced |
| Saturn V Capital Management LLC | 487,179 | $8.79M | 7.29% | +487,179 | New |
| Woodline Partners LP | 644,899 | $9.54M | 0.13% | +94,503+17.2% | Added |
| Cormorant Asset Management, LP | 650,000 | $9.62M | 0.65% | −350,000−35.0% | Reduced |
| Millennium Management LLC | 664,447 | $9.83M | 0.01% | +578,550+673.5% | Added |
| Westfield Capital Management Co LP | 680,374 | $10.1M | 0.08% | +210,600+44.8% | Added |
| Geode Capital Management, LLC | 779,144 | $11.5M | 0.00% | +44,900+6.1% | Added |
| Franklin Resources Inc | 797,736 | $11.8M | 0.01% | −1,260−0.2% | Reduced |
| Ameriprise Financial Inc | 813,622 | $12.0M | 0.00% | +158,944+24.3% | Added |
| Allspring Global Investments Holdings, LLC | 1,066,851 | $15.8M | 0.03% | +338,487+46.5% | Added |
| Point72 Asset Management, L.P. | 1,103,576 | $16.3M | 0.06% | −2,681,701−70.8% | Reduced |
| Holocene Advisors, LP | 1,145,143 | $16.9M | 0.10% | +1,004,141+712.1% | Added |
| Barclays PLC | 1,180,384 | $17.5M | 0.02% | +1,039,547+738.1% | Added |
| Jennison Associates LLC | 1,398,279 | $20.7M | 0.02% | +8,663+0.6% | Added |
| Logos Global Management LP | 1,400,000 | $20.7M | 2.43% | −125,000−8.2% | Reduced |
| GW&K Investment Management, LLC | 1,552,014 | $23.0M | 0.23% | +643,101+70.8% | Added |
| Pictet Asset Management SA | 1,638,933 | $24.3M | 0.04% | +36,147+2.3% | Added |
| Avidity Partners Management LP | 1,755,000 | $26.0M | 0.61% | +960,500+120.9% | Added |
| Polar Capital Holdings Plc | 2,005,777 | $29.7M | 0.24% | +696,509+53.2% | Added |
| OrbiMed Advisors LLC | 2,460,108 | $36.4M | 0.70% | −339,892−12.1% | Reduced |
| Vanguard Group Inc | 2,531,412 | $37.5M | 0.00% | +278,473+12.4% | Added |
| Rubric Capital Management LP | 2,742,519 | $40.6M | 1.78% | +2,270,472+481.0% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $44.4M | 4.96% | 00.0% | Unchanged |
| State Street Corp | 3,679,385 | $54.5M | 0.00% | +1,024,150+38.6% | Added |
| BlackRock Inc. | 5,214,258 | $77.2M | 0.00% | +132,514+2.6% | Added |
| Frazier Life Sciences Management, L.P. | 8,684,232 | $128.5M | 7.99% | 00.0% | Unchanged |
| FMR LLC | 9,139,173 | $135.3M | 0.01% | +209,942+2.4% | Added |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −274,330−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −172,848−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −167,816−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Swedbank AB | 0 | $0 | 0.00% | −36,600−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −26,324−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −22,126−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,081−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −18,349−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −12,900−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,296−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −4,774−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,032−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −711−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |